Plasmodium falciparum Monoclonal Antibody | Invitrogen MA1-27094 product information

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

Plasmodium falciparum Monoclonal Antibody

catalog :

MA1-27094

quantity :

500 ug

price :

US 464.00

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

reactivity :

malaria parasite P. falciparum

application :

western blot, ELISA, blocking or activating experiments

more info or order :

Invitrogen product webpage

citations: 2

Published Application/Species/Sample/Dilution	Reference
blocking or activating experiments; malaria parasite P. falciparum; fig 1	Pal P, Daniels B, Oskman A, Diamond M, Klein R, Goldberg D. Plasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis. MBio. 2016;7: pubmed publisher
	Harbuzariu A, Nti A, Harp K, Cespedes J, Driss A, Stiles J. Neuregulin-1/ErbB4 signaling modulates Plasmodium falciparum HRP2-induced damage to brain cortical organoids. iScience. 2022;25:104407 pubmed publisher

product information

Product Type :

Antibody

Product Name :

Plasmodium falciparum Monoclonal Antibody

Catalog # :

MA1-27094

Quantity :

500 ug

Price :

US 464.00

Clonality :

Monoclonal

Purity :

Antigen affinity chromatography

Host :

Mouse

Reactivity :

Protozoa

Applications :

ELISA: Assay-dependent, Western Blot: Assay-dependent

Species :

Protozoa

Isotype :

IgG1

Storage :

Store at 4 C short term. For long term storage, store at -20 C, avoiding freeze/thaw cycles.

Description :

Plasmodium falciparum is one of four species of Plasmodium which causes malaria in humans. Despite advances in the treatment of malaria, the disease remains one of the most important infectious diseases affecting humans. Malaria is the cause of approximately 2.5 million deaths per year with 200 million to 500 million new cases each year. The treatment of malaria has become more difficult with the emergence of drug resistant strains of Plasmodium. In particular, the widespread resistance of Plasmodium falciparum to chloroquine, one of the most effective dugs, has spurred the development of alternative drugs for the treatment of malaria.

Immunogen :

Histidine rich protein II from Plasmodium falciparum

Format :

Liquid

Applications w/Dilutions :

ELISA: Assay-dependent, Western Blot: Assay-dependent

Aliases :

P. falciparum

more info or order :

Invitrogen product webpage